CLGN vs LFWD: stock comparison and AI forecast
Collplant Biotechnologies Ltd (CLGN) and Lifeward Ltd. (LFWD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CLGN Collplant Biotechnologies Ltd
- Market Cap
- $7M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
LFWD Lifeward Ltd.
- Price
- $5.74 -15.1% · 6M
- Market Cap
- $16M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- LFWD is 2.2 times larger than CLGN by market capitalization ($16M against $7M).
- LFWD carries 1.87 times debt per unit of equity, against 0.77 times for CLGN.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CLGN | LFWD |
|---|---|---|
| Market Cap | $7M | $16M |
| P/B Ratio | 1.23x | 1.33x |
| EPS | $-2.39 | $-15.50 |
| Book Value/Share | $3.22 | $4.31 |
| Revenue/Share | $1.53 | $7.71 |
| FCF/Share | – | $-6.04 |
Profitability & Margins
| Metric | CLGN | LFWD |
|---|---|---|
| ROE | – | -252.4% |
| ROA | – | -88.1% |
| ROIC | – | -95.4% |
| Gross Margin | 14.8% | 36.0% |
| Operating Margin | -995.6% | -104.2% |
| Net Margin | – | -141.3% |
| EBT Margin | -995.6% | -141.5% |
| Tax Rate | – | 0.2% |
Financial Health
| Metric | CLGN | LFWD |
|---|---|---|
| Current Ratio | 2.53x | 2.33x |
| Quick Ratio | 2.31x | 1.77x |
| D/E Ratio | 0.77x | 1.87x |
| Financial Leverage | 1.77x | 2.87x |
| Interest Coverage | – | -0.6x |
| Working Capital | $4M | $15M |
Cash Flow
| Metric | CLGN | LFWD |
|---|---|---|
| Operating Cash Flow | -$24M | -$17M |
| Free Cash Flow | – | -$17M |
| Capital Spending | – | -$20K |
| FCF/Sales | – | -78.3% |
| CapEx/Sales | – | 0.1% |
Operational Efficiency
| Metric | CLGN | LFWD |
|---|---|---|
| Asset Turnover | 0.27x | 0.62x |
| Receivables Turnover | 2886.0x | 2.8x |
| Inventory Turnover | 4.3x | 1.9x |
| Fixed Assets Turnover | 2.0x | 41.4x |
| Days Sales Outstanding | 0 days | 131 days |
| Days Inventory | 85 days | 197 days |
| Payables Period | – | 197 days |
| Cash Conversion Cycle | – | 132 days |
Income Statement
| Metric | CLGN | LFWD |
|---|---|---|
| Total Revenue | $3M | $22M |
| Operating Income | -$29M | -$23M |
| Net Income | – | -$31M |
| R&D Expense | $19M | $9M |
| SG&A Expense | – | $23M |
| Cost of Goods Sold | $2M | $11M |
Dividend & Shareholder Information
| Metric | CLGN | LFWD |
|---|---|---|
| Shares Outstanding | 2M | 3M |
CLGN vs LFWD: stock comparison and AI forecast
Which is bigger, CLGN or LFWD?
LFWD is 2.2 times larger than CLGN by market capitalization ($16M against $7M).
Which one does Intratio's AI model rank higher, CLGN or LFWD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.